Reliability, Validity, and Cross-cultural Adaptation of the Turkish Version of the Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire

Sponsor
Gazi University (Other)
Overall Status
Completed
CT.gov ID
NCT04707274
Collaborator
(none)
103
1
14.6
7

Study Details

Study Description

Brief Summary

The purpose of this study was to investigate adaptation, validity, and reliability of the Turkish version of the Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire.

Condition or Disease Intervention/Treatment Phase
  • Other: Survey study

Detailed Description

Gluteal tendinopathy, also known as greater trochanteric pain syndrome, interferes with physical function and sleep, and is characterized by pain and tenderness over the greater trochanter.Clinical risk factors for the development of this condition include advanced age, female gender, back pain, overweight / obesity, poor abductor hip function, altered gait parameters, and psychological distress. The Victorian Institute of Sports Assessment for Gluteal tendinopathy (VISA-G) Questionnaire has recently designed as a patient-reported condition-specific outcome measurement tool to assess disability due to tendinopathy. VISA-G is scored between 0 and 100 (a higher score is expected) and consists of eight items covering three main areas (pain, function, and current activity level). Visual analog score for pain (0-10), the effect of pain on weight-bearing activities (0-30), and difficulty and / or function-related stairs use, including lying on the symptomatic side (0-10), climbing ramps (0-10), standing up without sitting (0-10), home or garden work (0-10) and regular exercise (0-10), physical activity and sports participation (0-10) are evaluated. The study is planned with 40 individuals with gluteal tendinopathy. After questioning the sociodemographic characteristics of the individuals, the patients will be asked to fill in VISA-G, Short Form-36, International Physical Activity Questionnaire, Numeric Rating Scale, Oswestry Disability Index, Oxford Hip Score and modified Harris Hip Score.Test-retest will be re-applied to those of the same individuals who can be reached after 1 week. The results will be analyzed using the SPSS version 22.0 computer package program.

Study Design

Study Type:
Observational
Actual Enrollment :
103 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Reliability, Validity, and Cross-cultural Adaptation of the Turkish Version of the Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire
Actual Study Start Date :
Feb 10, 2021
Actual Primary Completion Date :
Apr 1, 2022
Actual Study Completion Date :
May 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Patients group

Individuals with greater trochanteric pain syndrome and gluteal tendinopathy

Other: Survey study
Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire will be applied.

Outcome Measures

Primary Outcome Measures

  1. Victorian Institute of Sports Assessment for Gluteal Tendinopathy (VISA-G) Questionnaire [10 minutes]

    Victorian Institute of Sports Assessment for Gluteal Tendinopathy Questionnaire is designed to assess disability due to gluteal tendinopathy.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Trochanteric bursitis and/or gluteal tendinopathy,

  • Lateral hip pain,

  • Pain on palpation of the greater trochanter,

  • History of pain when lying on the ipsilateral side or during weight-bearing activities, aggravated by activity for more than 3 months.

Exclusion Criteria:
  • Hip osteoarthritis,

  • Systemic inflammatory disease such as rheumatoid arthritis,

  • Lumbar spine nerve root findings,

  • History of lumbar spine or ipsilateral hip joint surgery,

  • Osteogenic disease such as Paget's disease,

  • Corticosteroid injection to the ipsilateral hip in the past 3 months,

  • Hip surgery.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Halime ARIKAN Ankara None Selected Turkey 06490

Sponsors and Collaborators

  • Gazi University

Investigators

  • Principal Investigator: Seyit CITAKER, Dr., Gazi University, Faculty of Health Sciences
  • Principal Investigator: M. Baybars ATAOGLU, Dr., Gazi University, Faculty of Medicine
  • Principal Investigator: Gokhan MARAS, MSc., Gazi University, Faculty of Health Sciences
  • Principal Investigator: Halime ARIKAN, MSc., Ankara University, Faculty of Health Sciences
  • Principal Investigator: I. Hazal AYAS, MSc., Gazi University, Faculty of Health Sciences
  • Principal Investigator: Beyza YAZGAN DAGLI, MSc., Gazi University, Faculty of Health Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Halime ARIKAN, Research Assistant, Gazi University
ClinicalTrials.gov Identifier:
NCT04707274
Other Study ID Numbers:
  • 23.12.2020-E.137836
First Posted:
Jan 13, 2021
Last Update Posted:
May 27, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Halime ARIKAN, Research Assistant, Gazi University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 27, 2022